We are live on ! Find out more
LUXA

Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA

Delisted

LUXA was delisted on the 28th of October, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Lux Health Tech Acquisition Corp. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 72 → 0 (-72)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $301M → $0 (-$301M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 72

Holders
–
Holders Change
-72
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
72
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
ECP
Empyrean Capital Partners
California
-$30.1M
2
SC
Sculptor Capital
New York
-$20.2M
3
WAM
Weiss Asset Management
Massachusetts
-$18.1M
4
WH
Wolfswood Holdings
New York
-$14.4M
5
Marshall Wace
Marshall Wace
United Kingdom
-$13.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
26
Cubist Systematic Strategies
Connecticut
– -$4.08M -406,901 Closed
Millennium Management
27
Millennium Management
New York
– -$4.01M -400,000 Closed
JGC
28
J. Goldman & Co
New York
– -$3.95M -394,004 Closed
MC
29
Meteora Capital
Florida
– -$3.78M -377,372 Closed
FTCM
30
First Trust Capital Management
Illinois
– -$3.73M -372,959 Closed
RCM
31
Radcliffe Capital Management
Pennsylvania
– -$3.71M -370,982 Closed
SRF
32
Silver Rock Financial
California
– -$3.7M -369,442 Closed
Jane Street
33
Jane Street
New York
– -$3.54M -353,219 Closed
SIG
34
Senator Investment Group
New York
– -$3.44M -343,400 Closed
CL
35
CSS LLC
Illinois
– -$3.26M -325,209 Closed
MF
36
Magnetar Financial
Illinois
– -$3.25M -325,045 Closed
Bank of America
37
Bank of America
North Carolina
– -$3.25M -324,746 Closed
PMAM
38
Picton Mahoney Asset Management
Ontario, Canada
– -$2.75M -274,997 Closed
PC
39
Periscope Capital
Ontario, Canada
– -$2.66M -265,943 Closed
WRBC
40
W.R. Berkley Corp
Connecticut
– -$2.38M -238,169 Closed
UOC
41
UBS O'Connor
Illinois
– -$2.38M -237,619 Closed
CC
42
Centiva Capital
New York
– -$2.22M -221,300 Closed
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
– -$2.13M -212,807 Closed
TCA
44
Taconic Capital Advisors
New York
– -$2.06M -206,000 Closed
RCM
45
Rivernorth Capital Management
Florida
– -$2M -200,000 Closed
CM
46
Cohanzick Management
New York
– -$1.95M -194,879 Closed
RA
47
RiverPark Advisors
New York
– -$1.95M -194,879 Closed
BFM
48
Boothbay Fund Management
New York
– -$1.09M -109,174 Closed
NAM
49
Nexpoint Asset Management
Texas
– -$1.07M -106,700 Closed
DCM
50
Dupont Capital Management
Delaware
– -$1M -99,999 Closed
1
2
3

LUXA Hedge Fund Activity: Q4 2022 in Review

0 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) for Q4 2022, worth a combined $0 — down 100% from $301M a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of LUXA and 0 opened new positions — a net loss of 72 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Empyrean Capital Partners, exiting entirely with an estimated $30.1M sold.

  • 0 institutional investors held Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) as of Q4 2022, down from 72 in Q3 2022.
  • Funds reported $0 of Lux Health Tech Acquisition Corp. Class A Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Lux Health Tech Acquisition Corp. Class A Common Stock positions in Q4 2022 and 72 closed out, a net change of -72 holders.
  • The largest Lux Health Tech Acquisition Corp. Class A Common Stock seller in Q4 2022 was Empyrean Capital Partners, an estimated $30.1M sold.

Based on aggregated 13F filings for Q4 2022.